- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomic Medicine in Autism: Challenges and Opportunities
Authors
Keywords
Autism Spectrum Disorder, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Risperidone, Aripiprazole
Journal
PEDIATRIC DRUGS
Volume 17, Issue 2, Pages 115-124
Publisher
Springer Nature
Online
2014-12-01
DOI
10.1007/s40272-014-0106-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glix 13, a New Drug Acting on Glutamatergic Pathways in Children and Animal Models of Autism Spectrum Disorders
- (2014) Annamaria Chiara Santini et al. Biomed Research International
- Five-Fold Increase in National Prevalence Rates of Attention-Deficit/Hyperactivity Disorder Medications for Children and Adolescents with Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and other Psychiatric Disorders: A Danish Register-Based Study
- (2013) Søren Dalsgaard et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Drug discovery for autism spectrum disorder: challenges and opportunities
- (2013) Anirvan Ghosh et al. NATURE REVIEWS DRUG DISCOVERY
- The effect of the Taq1A variant in the dopamine D2 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys
- (2013) Yvette Roke et al. Pharmacogenetics and Genomics
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
- (2013) E L Nurmi et al. Translational Psychiatry
- Cluster Analysis of Autistic Patients Based on Principal Pathogenetic Components
- (2012) Roberto Sacco et al. Autism Research
- Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism
- (2012) S. J. Baudouin et al. SCIENCE
- Pathways to Drug Development for Autism Spectrum Disorders
- (2011) D R Hampson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism
- (2011) Joseph R. Moskal et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Gene expression in blood is associated with risperidone response in children with autism spectrum disorders
- (2011) L Lit et al. PHARMACOGENOMICS JOURNAL
- Pharmacologic Treatment of Behavioral Symptoms Associated With Autism and Other Pervasive Developmental Disorders
- (2010) Logan K. Wink et al. Current Treatment Options in Neurology
- Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene
- (2010) Pieter J. Hoekstra et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Clinical Genetic Testing for Patients With Autism Spectrum Disorders
- (2010) Y. Shen et al. PEDIATRICS
- Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk
- (2009) Maurizio Pompili et al. Expert Review of Neurotherapeutics
- Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study
- (2009) Kimberly A. Stigler et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Phenomic determinants of genomic variation in autism spectrum disorders
- (2009) Y Qiao et al. JOURNAL OF MEDICAL GENETICS
- Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions
- (2009) C T Correia et al. PHARMACOGENOMICS JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started